metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Infection prevention in solid organ transplantation
Journal Information
Vol. 30. Issue S2.
Infections in solid organ transplantation
Pages 27-33 (March 2012)
Share
Share
Download PDF
More article options
Vol. 30. Issue S2.
Infections in solid organ transplantation
Pages 27-33 (March 2012)
Full text access
Infection prevention in solid organ transplantation
Prevención de la infección en el trasplante de órgano sólido
Visits
3860
Joan Gavaldàa,
Corresponding author
gavaldasantapau@gmail.com

Corresponding author.
, Elisa Vidalb, Carlos Lumbrerasc
a Infectious Diseases Senior Consultant, Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain
b Infectious Diseases Senior Consultant, Infectious Diseases Department, Hospital General Reina Sofía, Córdoba, Spain
c Infectious Diseases Senior Consultant, Infectious Diseases Department, Hospital 12 de Octubre, Madrid, Spain
This item has received
Article information
Abstract

As complications from infection are a major cause of morbidity and mortality following transplantation, infection prevention is a cornerstone of any modern solid organ transplantation program. There is no doubt that, among other measures, antimicrobial prophylaxis has decreased the incidence and severity of posttransplant infections, and it is a major contributor to the currently improved survival rates of solid organ transplant recipients. This chapter is not a thorough analysis of all studies examining the prevention of infection following organ transplantation, but a practical guide to widely accepted recommendations regarding the prevention of common infections in the transplant setting, such as bacterial infections, including tuberculosis, cytomegalovirus, hepatitis viruses or invasive fungal infections.

Keywords:
Aspergillus
Cytomegalovirus
Infection
Prevention
Transplantation
Resumen

Debido a que las complicaciones infecciosas son una causa importante de morbimortalidad tras el trasplante, la prevención de la infección es fundamental en cualquier programa moderno de trasplante de órgano sólido. No hay duda de que, entre otros factores, la profilaxis antimicrobiana ha descendido la incidencia y la gravedad de las infecciones posteriores al trasplante y de que contribuye de forma importante a las actuales tasas mejoradas de supervivencia de los receptores de trasplante de órgano sólido. Este capítulo no es un análisis meticuloso de todos los estudios sobre prevención de la infección tras el trasplante de órgano, sino una guía práctica de las recomendaciones ampliamente aceptadas en relación con la prevención de las infecciones más frecuentes en el proceso del trasplante, como son las infecciones bacterianas como tuberculosis, citomegalovirus, hepatitis o infecciones fúngicas invasivas.

Palabras clave:
Aspergillus
Citomegalovirus
Infección
Prevención
Trasplante
Full text is only aviable in PDF
References
[1.]
J.A. Fishman.
Introduction: infection in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S3-S6
[2.]
J.A. Fishman, N.C. Issa.
Infection in organ transplantation: risk factors and evolving patterns of infection.
Infect Dis Clin North Am, 24 (2010), pp. 273-283
[3.]
L. Danzinger-Isakov, D. Kumar.
Guidelines for vaccination of solid organ transplant candidates and recipients.
Am J Transplant, 9 (2009), pp. S258-S262
[4.]
R.K. Avery, M.G. Michaels.
Strategies for safe living following solid organ transplantation.
Am J Transplant, 9 (2009), pp. S252-S257
[5.]
K.S. Gurusamy, Y. Kumar, B.R. Davidson.
Methods of preventing bacterial sepsis and wound complications for liver transplantation.
Cochrane Database Syst Rev, (2008),
[6.]
J.H. Zwaveling, J.K. Maring, I.J. Klompmaker, E.B. Haagsma, J.T. Bottema, M. Laseur, et al.
Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients.
Crit Care Med, 30 (2002), pp. 1204-1209
[7.]
S.H. Cohen, D.N. Gerding, S. Johnson, C.P. Kelly, V.G. Loo, L.C. McDonald, et al.
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).
Infect Control Hosp Epidemiol, 31 (2010), pp. 431-455
[8.]
E.R. Dubberke, D.J. Riddle.
Clostridium difficile in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S35-S40
[9.]
J.M. Aguado, J. Torre-Cisneros, J. Fortún, N. Benito, Y. Meije, A. Doblas, et al.
Consensus document for the management of tuberculosis in solid organ transplant recipients.
Enferm Infecc Microbiol Clin, 27 (2009), pp. 465-473
[10.]
J.M. Aguado, J. Torre-Cisneros, J. Fortún, N. Benito, Y. Meije, A. Doblas, et al.
Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.
Clin Infect Dis, 48 (2009), pp. 1276-1284
[11.]
J. Torre-Cisneros, M.A. Fariñas, J.J. Castón, J.M. Aguado, S. Cantisán, J. Carratalà, et al.
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
Enferm Infecc Microbiol Clin, 29 (2011), pp. 735-758
[12.]
U. Allen, J. Preiksaitis.
Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S87-S96
[13.]
S.A. Pergam, A.P. Limaye.
Varicella zoster virus (VZV) in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S108-S115
[14.]
J. Levitsky, K. Doucette.
Viral hepatitis in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S116-S130
[15.]
D. Kumar, E.A. Blumberg, L. Danziger-Isakov, C.N. Kotton, N.B. Halasa, M.G. Ison, et al.
Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations(dagger).
Am J Transplant, 11 (2011), pp. 2020-2030
[16.]
J. Fortún, J. Carratalà, J. Gavaldà, M. Lizasoain, M. Salavert, R. De la Camara, et al.
Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update.
Enferm Infecc Microbiol Clin, 29 (2011), pp. 435-454
[17.]
I. Ruiz-Camps, J.M. Aguado, B. Almirante, E. Bouza, C.F. Ferrer-Barbera, O. Len, et al.
Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).
Clin Microbiol Infect, 17 (2011), pp. 1-24
[18.]
S.I. Martin, J.A. Fishman.
Pneumocystis pneumonia in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S227-S233
Copyright © 2012. Elsevier España S.L.. All rights reserved
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos